Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy

Mmasa, K., Powis, K., Sun, S., Makhema, J., Mmalane, M., Kgole, S., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., Legbedze, J., Abrams, E., Kurland, I., Geffner, M., & Jao, J. (2021). Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir‐ than with efavirenz‐based antiretroviral therapy. HIV Medicine, 22(8), 715–722. Portico. https://doi.org/10.1111/hiv.13120
Authors:
K.N. Mmasa
K. Powis
S. Sun
J. Makhema
M. Mmalane
S. Kgole
G. Masasa
S. Moyo
M. Gerschenson
T. Mohammed
J. Legbedze
E.J. Abrams
I.J. Kurland
M.E. Geffner
J. Jao
Affiliated Authors:
E.J. Abrams
Author Keywords:
africa
dolutegravir
efavirenz
gestational diabetes
hiv
Publication Type:
Article
Unique ID:
10.1111/hiv.13120
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: